Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism

European Journal of Endocrinology

Volumn 162, Issue 5, 2010, Pages 925-933

  Tordjman, Karen M ^a   Yaron, Marianna ^a   Izkhakov, Elena ^a   Osher, Etty ^a   Shenkerman, Galina ^a   Marcus Perlman, Yonit ^a   Stern, Naftali ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIFEDIOL; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT; VITAMIN D;

ADULT; ARTERIAL STIFFNESS; ARTERY; ARTERY COMPLIANCE; ARTICLE; AUGMENTATION INDEX; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERCALCEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PULSE WAVE; RETROSPECTIVE STUDY; RIGIDITY; VITAMIN BLOOD LEVEL;

AGED; ARTERIES; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMPLIANCE; ELASTICITY; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PULSATILE FLOW; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77951660913     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1067     Document Type: Article

References (42)

1. Melton LJ III. The epidemiology of primary hyperparathyroidism in North America. Journal of Bone and Mineral Research 2002 17 (Suppl 2) N12-N17. (Pubitemid 35222307)
2. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M & Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 351-365.
3. Hedbäck G, Tisell LE, Bengtsson BA, Hedman I & Oden A. Premature death in patients operated on for primary hyperparathyroidism. World Journal of Surgery 1990 14 829-835.
4. Hedbäck G & Oden A. Increased risk of death from primary hyperparathyroidism - an update. European Journal of Clinical Investigation 1998 28 271-276. (Pubitemid 28188301)
5. Nilsson IL, Yin L, Lundgren E, Rastad J & Ekbom A. Clinical presentation of primary hyperparathyroidism in Europe - nationwide cohort analysis on mortality from nonmalignant causes. Journal of Bone and Mineral Research 2002 17 N68-N74. (Pubitemid 35222315)
6. Øgard CG, Engholm G, Almdal TP & Vestergaard H. Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark. World Journal of Surgery 2004 28 108-111.
7. Silverberg SJ & Bilezikian JP. Evaluation and management of primary hyperparathyroidism - author's response. Journal of Clinical Endocrinology and Metabolism 1997 82 983.
8. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM & Melton LJ III. Survival after the diagnosis of hyperparathyroidism: a population-based study. American Journal of Medicine 1998 104 115-122. (Pubitemid 28117404)
9. Hagström E, Lundgren E, Rastad J & Hellman P. Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. European Journal of Endocrinology 2006 155 33-39. (Pubitemid 44103372)
10. Heyliger A, Tangpricha V, Weber C & Sharma J. Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. Surgery 2009 146 1042-1047.
11. Rosenbloom SJ. Evaluation and management of primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1997 82 982-983.
12. Bollerslev J, Rosen T, Mollerup CL, Nordenström J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S & on behalf of the SIPH Study Group. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2009 94 2255-2261.
13. Tordjman KM, Greenman Y, Osher E, Shenkerman G & Stern N. Characterization of normocalcemic primary hyperparathyroidism. American Journal of Medicine 2004 117 861-863.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr & Roccella EJ. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. Journal of the American Medical Association 2003 289 2560-2572.
15. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183-1197. (Pubitemid 27274286)
16. Weisman Y, Reiter E & Root A. Measurement of 24,25 dihydroxyvitamin D in sera of neonates and children. Journal of Pediatrics 1977 36 904-907. (Pubitemid 8242151)
17. Azizi E, Pavlotsky F, Vered I & Kudish AI. Occupational exposure to solar UVB and seasonal monitoring of serum levels of 25-hydroxy vitamin D3: a case-control study. Photochemistry and Photobiology 2009 85 1240-1244.
18. Weisman Y. Osteoporosis and vitamin D deficiency in Israel. Public Health Reviews 2000 28 59-65.
19. Van Bortel LM, Duprez D, Starmans-Kool MS, Safar ME, Giannattasio C, Cockcroft J, Kaiaser DR & Thuillez C. Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. American Journal of Hypertension 2002 15 445-452. (Pubitemid 34478484)
20. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL & Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation 1997 95 1827-1836. (Pubitemid 27164400)
21. Pauca AL, O'Rourke MF & Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001 38 932-935.
22. Asmar R, Benetos A, Topoucian J, Laurent P, Pannier B, Brisac AM, Target R & Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995 26 485-490. (Pubitemid 26140679)
23. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P & Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001 37 1236-1241. (Pubitemid 34163575)
24. Finkelstein SM & Cohn JN. First- and third-order models for determining arterial compliance. Journal of Hypertension 1992 10 S11-S14.
25. Cohn JN, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J & Mock J. Pulse wave analysis for the early detection of vascular disease. Hypertension 1995 26 503-508.
26. Rennert G & Peterburg Y. Prevalence of selected chronic diseases in Israel. Israel Medical Association Journal 2001 3 404-408. (Pubitemid 34176916)
27. Luboshitzky R, Chertok-Shacham Y, Lavi I & Ishay A. Cardiovascular risk factors in primary hyperparathyroidism. Journal of Endocrinological Investigation 2009 32 317-321.
28. Duprez DA, Kaiser DR, Whitwam W, Finkelstein S, Belalcazar A, Patterson R, Glasser S & Cohn JN. Determinants of radial artery pulse wave analysis in asymptomatic individuals. American Journal of Hypertension 2004 17 647-653. (Pubitemid 39091544)
29. Smith JC, Page MD, John R, Wheeler MH, Cockcroft JR, Scanlon MF & Davies JS. Augmentation of central arterial pressure in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2000 85 3515-3519.
30. Rubin MR, Maurer MS, McMahon DJ, Bilezekian JP & Silverberg S. Arterial stiffness in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2005 90 3326-3330. (Pubitemid 41014293)
31. Barletta G, De Feo ML, Del Bene R, Lazzeri C, Vecchiarino S, La Villa G, Brandi ML & Franchi F. Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2000 85 1815-1821. (Pubitemid 32269282)
32. Oliver JJ & Webb DJ. Assessment of arterial stiffness and risk of atherosclerotic events. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 554-566. (Pubitemid 36438066)
33. Kosch M, Hausberg M, Vormbrock K, Kisters K, Rahn KH & Barenbrock M. Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. American Journal of Hypertension 2000 13 759-764. (Pubitemid 30604113)
34. Nuzzo V, Tauchmanova L, Fonderico F, Trotta R, Fittipaldi MR, Rossi R, Trimarco B & Lupoli G. Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. European Journal of Endocrinology 2002 147 453-459.
35. Fallo F, Camporese G, Capitelli E, Andreozzi GM, Matero F & Lumachi F. Ultrasound evaluation of carotid artery in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2003 88 2096-2099.
36. Kosch M, Hausberg M, Barenbrock M, Posadzy-Malaczynska A & Kis Ran RH. Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy. Clinical Nephrology 2001 55 303-308.
37. Lumachi F, Ermani M, Frego M, Pilon F, Filosa T, Di Cristofaro L, De Lotto F & Fallo F. Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case-control study and long-term follow-up. In Vitro 2006 20 887-890.
38. Rashid G, Bernheim J, Green J & Benchetrit S. Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrology, Dialysis, Transplantation 2007 22 2831-2837.
39. Nilsson IL, Aberg J, Rastad J & Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999 126 1049-1055.
40. Neunteufl T, Heher S, Prager G, Katzenschlager R, Abela C, Niederle B & Stefeneli T. Effects of successful parathyroidectomy on altered arterial reactivity in patients withhypercalcaemia: results of a 3-year follow-up study. Clinical Endocrinology 2000 53 229-233.
41. Kosch M, Hausberg M, Vormbrock K, Kisters K, Gabriels G, Rahn KH & Barenbrock M. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovascular Research 2000 47 813-818.
42. Nilsson IL, Rastad J, Johansson K & Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001 130 986-990.